Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis – A Single-Center Retrospective Longitudinal Study
Andrea Miniello, Francesco Pugliese, Ilaria Pepe, Giovanna Pastore, Maria Lassandro, Chiara Calabrese, Eustachio Nettis · 2026
Read Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis – A Single-Center Retrospective Longitudinal Study by Andrea Miniello, Francesco Pugliese, Ilaria Pepe, Giovanna Pastore, Maria Lassandro, Chiara Calabrese, Eustachio Nettis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13155717.txt.
Description
Andrea Miniello and co-authors followed patients with severe atopic dermatitis treated with dupilumab in two thousand twenty-six. Atopic dermatitis is a chronic eczema that can dominate daily life. The team tracked not just skin scores but how much control patients felt over their disease.
Sixty-one patients who stayed on treatment for at least a year were included. By four months, most had reached good scores for skin, life quality, and itch, though only about half met strict control targets. By twelve months, more than four fifths met each target, and nearly all had gained a meaningful improvement in control. The authors conclude the drug gave steady disease control over the year.
Catalog record
| CREATOR | Andrea Miniello, Francesco Pugliese, Ilaria Pepe, Giovanna Pastore, Maria Lassandro, Chiara Calabrese, Eustachio Nettis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |